Upcoming FDA-AACR Workshop Will Discuss DPD Deficiency Testing
A FDA-AACR workshop will discuss the considerations for DPD deficiency testing before chemotherapy with fluoropyrimidines.
Related Articles
The Trouble with Elon
I didn’t set out to become an enemy of the world’s richest man, but I seem to have managed it all the same.
How I Treat Anemia in Myelofibrosis
Anemia is a common consequence of myelofibrosis. The treatment of myelofibrosis-associated anemia is complicated by a multifactorial pathobiology, as well
How a Hospital Chain Used a Poor Neighborhood to Turn Huge Profits (Published 2022)
Bon Secours Mercy Health, a major nonprofit health system, used the poverty of Richmond Community Hospital’s patients to tap into a lucrative federal drug program.
Group 6
This year’s HCC Day on the 27th February 2025 will take place in Bern, Switzerland and can be joined online as well. If you want…
2025 FDA-AACR Workshop: DPD Deficiency and Weighing Potential Harms
AACR is hosting a workshop with the FDA on January 16, 2025, to discuss the considerations for routine testing of DPD deficiency before treatment with…
Concomitant HIV‐associated plasmablastic lymphoma and visceral leishmaniasis at initial presentation
Click on the article title to read more.
Red Dye #3 is out, and boosters may get RCTs: Why is the evidence to remove a chemical from food LESS THAN the evidence to recommend a medical interventions?
Things we don’t teach well in medical school
USPSTF Recommendation: Screening for Osteoporosis to Prevent Fractures
This 2025 Recommendation Statement from the US Preventive Services Task Force recommends screening for osteoporosis to prevent osteoporotic fractures in women 65 years or older…
Red dye No. 3: FDA bans ingredient from food | CNN
The US Food and Drug Administration has banned the use of red dye No. 3 in food and beverages.
